Wells Fargo’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $148K | Buy |
15,457
+6,104
| +65% | +$58.4K | ﹤0.01% | 4553 |
|
2025
Q1 | $87K | Sell |
9,353
-140
| -1% | -$1.3K | ﹤0.01% | 4727 |
|
2024
Q4 | $132K | Buy |
9,493
+3,236
| +52% | +$45K | ﹤0.01% | 4557 |
|
2024
Q3 | $147K | Sell |
6,257
-249
| -4% | -$5.85K | ﹤0.01% | 4385 |
|
2024
Q2 | $104K | Buy |
6,506
+1,781
| +38% | +$28.5K | ﹤0.01% | 4559 |
|
2024
Q1 | $77.5K | Buy |
4,725
+652
| +16% | +$10.7K | ﹤0.01% | 4669 |
|
2023
Q4 | $56.4K | Buy |
4,073
+843
| +26% | +$11.7K | ﹤0.01% | 4812 |
|
2023
Q3 | $44.5K | Sell |
3,230
-2,282
| -41% | -$31.4K | ﹤0.01% | 4890 |
|
2023
Q2 | $93.9K | Buy |
5,512
+3,150
| +133% | +$53.6K | ﹤0.01% | 4815 |
|
2023
Q1 | $38K | Buy |
+2,362
| New | +$38K | ﹤0.01% | 5015 |
|
2022
Q4 | – | Sell |
-39
| Closed | – | – | 7377 |
|
2022
Q3 | $0 | Sell |
39
-114
| -75% | – | ﹤0.01% | 7049 |
|
2022
Q2 | $1K | Sell |
153
-2,409
| -94% | -$15.7K | ﹤0.01% | 6318 |
|
2022
Q1 | $27K | Sell |
2,562
-4,489
| -64% | -$47.3K | ﹤0.01% | 5574 |
|
2021
Q4 | $99K | Buy |
+7,051
| New | +$99K | ﹤0.01% | 5241 |
|